Introduced
August 13, 2026
Ms. Hoyle of Oregon (for herself, Mr. Doggett, Ms. Stansbury, Mr. Takano, Ms. Norton, Ms. Tlaib, Ms. Jayapal, and Mr. Casar) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026”.